TSX:BHC (Bausch Health Companies Inc.)

About BHC

Bausch Health Companies Inc. is a global company that develops manufactures and markets a range of pharmaceutical medical device and over-the-counter products primarily in the therapeutic areas of eye health gastroenterology and dermatology. We are delivering on our commitments as we build an innovative company dedicated to advancing global health. Our approximately 22000 employees are united around our mission of improving peoples lives with our health care products and we manufacture and market health care products directly or indirectly in approximately 100 countries. Five pillars or guiding principles represent the foundation on which we are realizing our mission as an organization: People Quality Health Care Outcomes Customer Focus Innovation and Efficiency.
  • Bausch Health Companies Inc. (TSX: BHC) Latest News

    The Motley Fool
    Investing

    2 Reasons to Buy Valeant Pharmaceuticals Intl. Inc.

    Valeant Pharmaceuticals Intl. Inc. (TSX:VRX)(NYSE:VRX) continues to rise in price and market cap, making it a great choice for your…

    Read more »

    The Motley Fool
    Dividend Stocks

    3 Diversified Stock Picks for Long-Term Investors

    Looking for a long-term play? If so, Computer Modelling Group Ltd. (TSX:CMG), Extendicare Inc. (TSX:EXE), and Valeant Pharmaceuticals Intl. Inc.…

    Read more »

    The Motley Fool
    Investing

    Could the CEO of Valeant Pharmaceuticals Intl Inc. Be the Next Warren Buffett?

    Warren Buffett has grown his empire by buying great companies. The CEO of Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) is doing…

    Read more »

    The Motley Fool
    Investing

    Billionaire John Paulson Doubles Down on Valeant Pharmaceuticals Intl Inc.

    Billionaire John Paulson owns $400 million of Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX). Should you buy, too?

    Read more »

    The Motley Fool
    Investing

    Is Valeant Pharmaceuticals Intl Inc. Another Berkshire Hathaway?

    Based on Bill Ackman's logic, Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) is perpetually undervalued because the companies it buys consistently push…

    Read more »

    The Motley Fool
    Investing

    Deal-Making Valeant Pharmaceuticals Intl Inc. Shows No Signs of Slowing Down

    Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) dominates the TSX’s health care group, but there are other stocks in the sector worth…

    Read more »

    The Motley Fool
    Investing

    Can Valeant Pharmaceuticals Intl Inc. Continue its Meteoric Rise?

    Here's why I'm not so optimistic about Valeant Pharmaceuticals Intl Inc. (TSX: VRX)(NYSE: VRX).

    Read more »

    The Motley Fool
    Investing

    Why Is Warren Buffett’s Right-Hand Man so Bearish on Valeant Pharmaceuticals Intl Inc.?

    Charlie Munger does not have nice things to say about Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX). But is that enough of…

    Read more »

    The Motley Fool
    Investing

    Valeant Pharmaceuticals Intl Inc. Acquired Salix Pharmaceuticals Ltd.:Now What?

    Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) has finished buying another company. Could a $2 billion product be the reason to buy…

    Read more »

    The Motley Fool
    Investing

    Is Valeant Pharmaceuticals Inc. a Soaring Rocket or a Hot Air Balloon?

    Valeant Pharmaceuticals Inc. (TSX:VRX)(NYSE:VRX) has been a big win for its shareholders. Just how long can the good times last?

    Read more »

    Investing

    Should You Buy Valeant Pharmaceuticals Intl Inc. on the Salix Pharmaceuticals, Ltd. Acquisition News?

    I would hold for a dip on Valeant Pharmaceuticals Intl. Inc. (TSX:VRX)(NYSE:VRX) before buying on its recent acquisition news.

    Read more »

    Investing

    Is Valeant Pharmaceuticals Intl Inc a $250 Stock?

    Barclays analysts see Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) as an overlooked growth story. Is now the time to buy?

    Read more »